Biogen (BIIB)
(Delayed Data from NSDQ)
$221.50 USD
-1.25 (-0.56%)
Updated May 10, 2024 04:00 PM ET
After-Market: $221.54 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/23/2024
Time: -- |
6/2024 | $3.96 | 0.50% |
Earnings Summary
For their last quarter, Biogen (BIIB) reported earnings of $3.67 per share, beating the Zacks Consensus Estimate of $3.45 per share. This reflects a positive earnings surprise of 6.38%. Look out for BIIB's next earnings release expected on July 23, 2024. For the next earning release, we expect the company to report earnings of $3.96 per share, reflecting a year-over-year decrease of 1.49%.
Earnings History
Price & Consensus
Zacks News for BIIB
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
BIIB: What are Zacks experts saying now?
Zacks Private Portfolio Services